Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia.

Autor: Achtyes, Eric D.1 (AUTHOR), Hopkins, Seth C.2 (AUTHOR), Dedic, Nina2 (AUTHOR), Dworak, Heather2 (AUTHOR), Zeni, Courtney2 (AUTHOR) Courtney.Zeni@Sunovion.com, Koblan, Kenneth2 (AUTHOR)
Zdroj: European Archives of Psychiatry & Clinical Neuroscience. Oct2023, Vol. 273 Issue 7, p1543-1556. 14p. 1 Diagram, 5 Charts, 4 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje